A detailed history of Natixis transactions in Pfizer Inc stock. As of the latest transaction made, Natixis holds 2,876,901 shares of PFE stock, worth $80.5 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,876,901
Previous 1,817,465 58.29%
Holding current value
$80.5 Million
Previous $52.3 Million 52.58%
% of portfolio
0.42%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $27.4 Million - $31.5 Million
1,059,436 Added 58.29%
2,876,901 $79.8 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $20.2 Million - $26.2 Million
773,030 Added 74.01%
1,817,465 $52.3 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $5.41 Million - $6.32 Million
-168,528 Reduced 13.89%
1,044,435 $34.6 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $4.77 Million - $5.52 Million
-132,004 Reduced 9.81%
1,212,963 $44.5 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $66.4 Million - $86.5 Million
-1,686,404 Reduced 55.63%
1,344,967 $54.9 Million
Q4 2022

Feb 24, 2023

SELL
$41.75 - $54.5 $44.1 Million - $57.5 Million
-1,055,517 Reduced 25.83%
3,031,371 $155 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $55.6 Million - $72.6 Million
1,331,922 Added 48.35%
4,086,888 $209 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $14.4 Million - $17.6 Million
329,888 Added 13.6%
2,754,966 $121 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $45.3 Million - $53.7 Million
972,608 Added 66.96%
2,425,078 $126 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $1.68 Million - $2.09 Million
-36,805 Reduced 2.47%
1,452,470 $75.2 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $60.8 Million - $90.1 Million
-1,471,285 Reduced 49.7%
1,489,275 $87.3 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $111 Million - $143 Million
-2,839,815 Reduced 48.96%
2,960,560 $127 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $159 Million - $180 Million
4,414,933 Added 318.67%
5,800,375 $227 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $108 Million - $122 Million
-3,228,887 Reduced 69.98%
1,385,442 $50.2 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $26.8 Million - $34 Million
799,849 Added 20.97%
4,614,329 $170 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $102 Million - $119 Million
3,207,172 Added 528.1%
3,814,480 $140 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $82.7 Million - $100 Million
-2,745,964 Reduced 81.89%
607,308 $19.9 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $48.2 Million - $68.9 Million
1,783,777 Added 113.65%
3,353,272 $109 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $3.04 Million - $3.45 Million
92,212 Added 6.24%
1,569,495 $61.1 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $146 Million - $189 Million
-4,489,142 Reduced 75.24%
1,477,283 $53.1 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $221 Million - $248 Million
5,966,425 New
5,966,425 $258 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $144 Million - $158 Million
-3,827,957 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $13 Million - $14.8 Million
-337,079 Reduced 8.09%
3,827,957 $166 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $45.3 Million - $54.9 Million
1,314,227 Added 46.1%
4,165,036 $184 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $55.5 Million - $59.2 Million
1,683,117 Added 144.14%
2,850,809 $103 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $93.4 Million - $108 Million
-2,926,062 Reduced 71.48%
1,167,692 $41 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $19.8 Million - $21 Million
594,123 Added 16.98%
4,093,754 $148 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $24 Million - $26.4 Million
772,738 Added 28.34%
3,499,631 $125 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,726,893
2,726,893 $91.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.